Context: Supraphysiological estradiol exposure after ovarian stimulation may disrupt embryo implantation after fresh embryo transfer. Women with polycystic ovary syndrome (PCOS), who usually overrespond to ovarian stimulation, have a better live birth rate after frozen embryo transfer (FET) than after fresh embryo transfer; however, ovulatory women do not.
T he introduction of ovarian stimulation has greatly optimized the success rate of in vitro fertilization (IVF) treatment. Ovarian stimulation multiplies the number of oocytes and increases the cumulative live birth rate of an IVF cycle (1) . However, it concurrently results in supraphysiological levels of steroid hormones and cytokines (2, 3) . Preclinical studies showed that the excessive level of estradiol after ovarian stimulation, especially in high responders (4) , adversely affects endometrial receptivity. Elevated levels of estradiol are associated with altered expression of numerous genes during the window of implantation (5) and asynchrony between endometrial gland and stroma development (6) . Ovarian stimulation was also found to change the pattern of uterine peristalsis (7) .
Evidence from clinical observations suggests that high ovarian response (i.e., a large number of oocytes retrieved or high estradiol concentration) has an adverse effect on pregnancy outcomes after fresh embryo transfer. Largescale registry studies showed the live birth rate after fresh embryo transfer steadily increased with the number of oocytes retrieved up until an oocyte number of 15 (8, 9) , but it then declined when the oocyte number exceeds this threshold (8) . Studies also reported a lower pregnancy rate after fresh embryo transfer in women with a higher peak estradiol level (peak estradiol level . 4000 pg/mL) than in women with lower estradiol levels. (10) (11) (12) A "freeze-all" strategy [i.e., electively freezing all embryos and then performing a frozen embryo transfer (FET)] could avoid exposure of the endometrium and the implanted embryos to the supraphysiological estradiol levels and thus may result in better pregnancy outcomes (13, 14) . Hypothetically, any women with a high ovarian response would benefit more from elective FET than would women with a normal or low ovarian response.
Our team has completed two large multicenter randomized controlled trials comparing the live birth rate after frozen vs fresh embryo transfer in 1508 women with polycystic ovary syndrome (PCOS) (15) and in 2157 ovulatory women (16) , respectively. The two trials yielded different results. In women with PCOS (15) , FET compared with fresh embryo transfer resulted in a higher rate of live birth and a lower risk for pregnancy loss. In contrast, among ovulatory women (16) , the rates of live birth and pregnancy loss were similar after frozen and fresh embryo transfer. The underlying mechanism for this discrepancy between different populations is unclear.
However, women with PCOS usually have a higher ovarian response to ovarian stimulation and generally yield more oocytes, along with a higher peak level of estradiol, than do ovulatory women. Observational studies showed that with regard to the implantation rate and ongoing pregnancy rate, the benefit of frozen over fresh embryo transfer was present only in women with a high ovarian response (i.e., women with 10 to 15 oocytes), not in women with four to nine oocytes (17) . Nonetheless, the allocation to fresh or FET wasn't random in these two studies, and thus selection bias is a possible explanation for the finding.
Further investigation is necessary to determine whether the relative effect of frozen vs fresh embryo transfer varies with ovarian response. In the current study, we combined the data from our two randomized trials and did a post hoc analysis comparing the effect of frozen vs fresh embryo transfer on pregnancy outcomes according to ovarian response, as defined by number of oocytes retrieved and peak estradiol level.
Materials and Methods

Design of the trials
Both of the trials (in women with PCOS and in ovulatory women) were designed to compare the live birth rate after FET vs fresh embryo transfer. The enrollment of the former trial was conducted in 14 reproductive medical centers between June 2013 and May 2014 and the latter in 20 centers between March 2015 and November 2015. Twelve sites participated in both trials. We have previously published the main outcome results of these two trials (15, 16) , and the study protocols are available online at http://www.nejm.org/doi/full/10.1056/ NEJMoa1513873 and http://www.nejm.org/doi/full/10.1056/ NEJMoa1705334. Both trials were approved by the ethics committees of all study sites, and all of the participants provided written informed consent.
The study protocols used in the two trials were nearly the same in terms of intervention and study outcomes but were different in the study population inclusion criteria (Supplemental Table 1 ). In brief, the trial in women with PCOS included women with the diagnosis of PCOS by the presence of menstrual irregularity combined with hyperandrogenism or polycystic ovaries. The trial in ovulatory women included women with regular menstrual cycle and excluded women with the diagnosis of PCOS. A gonadotropin-releasing hormone antagonist regimen was used for ovarian stimulation in both trials. Follicle growth was monitored by serial ultrasonography and sex hormone measurements performed at the participating sites. The dose adjustment of gonadotropin was the same in these two trials. Human chorionic gonadotropin (hCG) was administered to trigger the final oocyte maturation when two or more follicles measured $18 mm in the mean diameter.
On the day of oocyte retrieval, in both trials eligible patients were randomly assigned to two parallel groups: the fresh embryo transfer group or the FET group. For patients assigned to the fresh embryo transfer group, luteal phase support was started on the day of oocyte retrieval and two cleavagestage embryos were transferred. For patients assigned to the FET group, no luteal phase support was given; all embryos were vitrified.
In the trial for women with PCOS, because of the feature of oligoovulation or anovulation, all patients in the FET group underwent a hormone replacement regimen for endometrial preparation (i.e., a programmed cycle). In the trial of ovulatory women, 74.2% of patients had FET after natural ovulatory cycle and 25.8% patients had FET after a programmed cycle using a hormone replacement regimen for endometrial preparation (16) . Two cleavage-stage embryos were thawed and transferred. For patients with a positive result on a serum hCG test on 12 to 15 days after embryo transfer, luteal phase support was continued till 10 weeks' gestation. All pregnancies were followed up until delivery or termination. The primary outcome was live birth after the first transfer. The definitions of the study outcomes were as published previously (15) .
Statistical analysis
The baseline characteristics of patients were summarized by using frequencies and percentages for categorical variables and means 6 standard deviations (for normally distributed data) and medians with interquartile ranges (for non-normally distributed data) for continuous variables. The differences in baseline characteristics between women with PCOS and ovulatory women were compared with a x 2 test or Fisher exact test when needed for categorical variables and with a Student t test for normally distributed continuous variables and Mann-Whitney U test for nonnormally distributed continuous variables.
The pregnancy outcomes in this study included clinical pregnancy, clinical pregnancy loss, and live birth. To evaluate the effect of ovarian response on pregnancy outcomes after frozen and fresh embryo transfer, two series of multivariable logistic regression models were built in women with PCOS and in ovulatory women, respectively, with backward process for variable selection. The first serial models included age, body mass index (BMI), duration of infertility, previous pregnancy, oocyte number (as a continuous variable), randomization groups (frozen vs fresh embryo transfer), and interaction between randomization groups and oocyte number. The second serial models included age, BMI, duration of infertility, previous pregnancy, peak estradiol level (estradiol level on the day of hCG administration, as a continuous variable), randomization groups, and interaction between randomization groups and estradiol level. A significant interaction was defined as P value # 0.05. We graphed the trend in pregnancy outcomes after frozen and fresh embryo transfer with oocyte number and peak estradiol level, separately, by using moving average with a window size of 3. In the graphs, peak estradiol level was cut into 20 bins by every 5%. Cutoff values for subgroups were determined by incorporating results of logistic regression model and visualization on graphs.
The pregnancy outcomes between the frozen and fresh embryo transfer groups were described as frequencies and percentages and were compared by x 2 test in each subgroup. The ORs and 95% CIs were calculated by using logistic regression analysis. All of the analyses were performed by using the Statistical Package for the Social Sciences, version 21.0 (IBM, Chicago, IL).
Results
Baseline characteristics
The baseline characteristics of women with PCOS and ovulatory women are described in Table 1 . As expected, women with PCOS had more oocytes retrieved (14.3 6 5.9 vs 12.4 6 5.2; P , 0.001) and a higher peak level of estradiol [3859 (interquartile range, 2605 to 5460) vs 2809 (interquartile range, 2058 to 3868) pg/mL; P , 0.001] than did ovulatory women.
Multivariable logistic regression models
In women with PCOS, after adjustment for age, BMI, duration of infertility, and previous pregnancy, the interaction between oocyte number and randomization groups (frozen vs fresh embryo transfer) was statistically significant for the rates of clinical pregnancy loss and live birth (P , 0.001) (Supplemental Table 2 ). There was also a significant interaction between peak estradiol level and randomization groups for the rates of clinical pregnancy loss and live birth (P , 0.001) (Supplemental Table 3 ). The significant interaction indicated that the effect of frozen vs fresh embryo transfer on the rates of clinical pregnancy loss and live birth varied with oocyte number and peak estradiol level.
In ovulatory women, neither the interaction between oocyte number and randomization groups nor the interaction between peak estradiol level and randomization groups was statistically significant for any pregnancy outcome (Supplemental Tables 4 and 5 ).
Graphs for trends in pregnancy outcomes and cutoff values selection
In women with PCOS, according to graphs for the live birth rate, the pattern of the difference between frozen and fresh embryo transfer changed at the points of 9 and Fig. 1(C) ] and also at the point of the eighth group of estradiol level (3069 to 3305 pg/mL) [ Fig. 2(C) ]. However, in ovulatory women, no apparent trend in the difference in pregnancy outcomes between frozen and fresh embryo transfer was seen, which was consistent with the logistic regression results.
On the basis of number of oocytes retrieved, study populations were categorized into three subgroups: women with #9 oocytes, women with 10 to 15 oocytes, and women with $16 oocytes, which were consistent with the cutoff values for ovarian response categories reported in the literature (17, 18) . According to peak estradiol levels, patients were classified into two subgroups: women with estradiol level of #3000 pg/mL and women with estradiol level of .3000 pg/mL.
Pregnancy outcomes in subgroups based on oocyte number
In women with PCOS and nine or fewer oocytes, FET resulted in a lower rate of clinical pregnancy loss than did fresh embryo transfer (14.3% vs 27.0%; OR, 0.45; 95% CI, 0.21 to 0.96) ( Table 2 ). The rates of clinical pregnancy and live birth did not differ significantly between the frozen and fresh embryo transfer groups. In women with PCOS and 10 to 15 oocytes, the rates of clinical pregnancy, clinical pregnancy loss, and live birth were similar after frozen and fresh embryo transfer. In women with PCOS and 16 or more oocytes, compared with fresh embryo transfer, FET was associated with a lower rate of clinical pregnancy loss (14.7% vs 26.3%; OR, 0.48; 95% CI, 0.28 to 0.82) and a higher rate of live birth (54.8% vs 42.1%; OR, 1.67; 95% CI, 1.20 to 2.31).
In ovulatory women with any subgroups of oocyte number, the rates of clinical pregnancy, clinical pregnancy loss, and live birth were similar between the frozen and fresh embryo transfer groups.
Pregnancy outcomes in subgroups based on peak estradiol level
In women with PCOS and peak estradiol level # 3000 pg/mL, the rates of clinical pregnancy, clinical pregnancy loss, and live birth were similar between the frozen and fresh embryo transfer groups (Table 3 ). However, in women with PCOS and peak estradiol level . 3000 pg/mL, FET resulted in a lower rate of clinical pregnancy loss (11.6% vs 26.3%; OR, 0.37; 95% CI, 0.23 to 0.57) and a higher rate of live birth (51.9% vs 40.7%; OR, 1.57; 95% CI, 1.22 to 2.03). In contrast, in ovulatory women, the rates of clinical pregnancy, clinical pregnancy loss, and live birth were similar after frozen and fresh embryo transfer, regardless of peak estradiol level.
Discussion
In this post hoc subgroup analysis of two large randomized trials, we found that the relative effect of FET vs fresh embryo transfer on pregnancy outcomes varied between women with PCOS and ovulatory women independently of ovarian response. In women with PCOS, FET resulted in a lower rate of clinical pregnancy loss and a higher rate of live birth than did fresh embryo transfer in those who were relatively overstimulated, but not in those who were comparatively normally stimulated. In ovulatory women, regardless of ovarian response, the rates of pregnancy, pregnancy loss, and live birth were similar after frozen and fresh embryo transfer.
These results suggested that the different results of our two trials in women with PCOS and in ovulatory women may be due to factors other than the difference in ovarian response. Previous studies (19, 20) suggested that women with PCOS had an increased risk for pregnancy loss compared with women without PCOS. A higher rate of miscarriage after fresh embryo transfer in women with PCOS than the non-PCOS controls (34.2% vs 17.1%; P = 0.025) was also reported (21) . Nonetheless, the rate of aneuploidy in aborted pregnancies among women with PCOS was not higher than among normal controls (22, 23) . The underlying mechanism for the increased risk for pregnancy loss in women with PCOS is unclear; however, concomitant obesity, hyperinsulinemia, and hyperandrogenism were suggested as potential contributors (19, 24) .
Our results also showed the rate of pregnancy loss after fresh embryo transfer was higher than that after FET in women with PCOS and a higher ovarian response. However, this phenomenon was not observed in ovulatory women. Other factors in women with PCOS may make them more vulnerable to the supraphysiological estradiol environment. Supporting evidence includes that the endometrial expression level of estrogen receptor in the proliferative phase of the menstrual cycle was significantly higher in women with PCOS than in the non-PCOS control women (25, 26) . It is possible that the highly reactive endometrium together with the high level of cytokines (27, 28) makes the uterine environment unfavorable for pregnancy maintenance. Previous studies in high responders showed supraphysiological estradiol levels after ovarian stimulation were associated with endometrial advancement (29, 30) , altered expression of numerous endometrial genes during the window of implantation (5), and changed endometrial immunologic status (31) , all of which may adversely affect embryo implantation and early placentation. Moreover, further studies are needed to elucidate the interplay between the PCOS-specific features (such as hyperandrogenism, hyperinsulinemia, and metabolic alterations) and the effect of ovarian stimulation. Additionally, in women with PCOS, because of the unpredictability of menses, oral contraceptives are frequently administered to induce withdrawal bleeding for scheduling the start of IVF treatment. Pretreatment with oral contraceptives may exacerbate the adverse effect of supraphysiological level of estradiol or other analytes on the endometrium. Our previous secondary analysis in women with PCOS showed oral contraceptive pretreatment had a worse impact on the outcome of fresh embryo transfer than on that of FET (32) .
In women with PCOS, there was a discrepancy between the subgroups based on oocyte number and the subgroups based on peak estradiol level, although the oocyte number was positively correlated with the https://academic.oup.com/jcempeak estradiol level. In the subgroup with nine or fewer oocytes, the rate of clinical pregnancy loss was lower after FET than after fresh embryo transfer. However, in the subgroup of peak estradiol level # 3000 pg/mL, the rate of clinical pregnancy loss was similar between the frozen and fresh embryo transfer groups. Because of the high risk for ovarian hyperstimulation syndrome, decreasing gonadotropin dose or coasting by withholding gonadotropin is often performed in women with PCOS; this usually resulted in fewer oocytes at retrieval but still led to a high peak estradiol level. From this perspective, the cutoff value of peak estradiol level is more accurate than that of oocyte number for determining whether a "freeze-all" strategy should be performed. In ovulatory women, FET resulted in similar rates of pregnancy, pregnancy loss, and live birth, regardless of ovarian response. This finding suggests that ovarian stimulation and its associated endometrial changes are not inevitably associated with adverse pregnancy outcomes. These findings are consistent with those of another randomized trial in Vietnamese women without PCOS (33) . However, two other trials reported a higher rate of pregnancy after FET than after fresh embryo transfer (34, 35) . Neither trial specified whether women with PCOS were excluded. Moreover, in those two trials, blastocyst transfer was performed in patients who were assigned to the FET group, whereas in our study (16) and in the Vietnamese trials (33), cleavage-stage embryos were transferred. The different stage of embryo freezing may also contribute to the inconsistent results.
This study had several strengths. First, the two trials included in this analysis had overlapping study sites and a very similar design, including the multicenter design, the standard ovarian stimulation regimen, the same embryo stage for transferring and freezing, and the common definition and tracking of pregnancy outcomes, all of which increased the comparability between the two trials. Second, the large sample size in both trials enabled us to have a relatively large number of patients in each subgroup. Nonetheless, several limitations in this study should be considered. First, because was a post hoc subgroup analysis of two randomized controlled trials, the sample size was previously determined in the original studies according to the primary outcome. Type I and type II errors were not controlled a priori. Second, the peak estradiol level was measured in local laboratories for clinical monitoring; the variance between different laboratories was not purposely controlled. Third, the cutoff values for our subgroup analysis could still be viewed as more or less arbitrary though they were data-driven cutoffs and consistent with cutoffs in other populations (17, 18) . Further studies in each specific population or stratified randomized trials are needed to confirm our results. Fourth, the current analysis Additionally, in both of these two studies, women with fewer than three oocytes were excluded. We should be cautious in extrapolating the results to women with poor ovarian response.
In conclusion, the difference in pregnancy outcomes after fresh vs frozen transfer between women with PCOS and ovulatory women is independent of ovarian response. In women with PCOS, FET seems to be superior to fresh embryo transfer for women with a high ovarian response (i.e., peak estradiol level . 3000 pg/ mL or $16 oocytes). However, in ovulatory women, FET seems to be as efficacious as fresh embryo transfer for achieving pregnancy and live birth regardless of the ovarian response levels. Further studies are needed to replicate our findings and establish mechanisms for varying pregnancy and live birth rates. 
